Jushi Holdings (CSE: JUSH) (OTC: JUSHF) - Investor Dashboard

Summary

Financials (06/30/20)

Capital Structure (08/26/20)

Company Brief

Jushi Holdings Inc. (Follow Company) is a vertically integrated multi-state cannabis and hemp operator across the United States. The globally-focused company operates a diverse portfolio of branded cannabis and hemp-derived assets, built upon opportunistic acquisitions, distressed deals and competitive applications.

Operating under the Jushi umbrella is the BEYOND / HELLO retail brand of cannabis dispensaries, hemp-based CBD brand, Nira, and the soon to be introduction of a comprehensive suite of brands, including its award-winning brands, ‘The Lab: Concentrates’ and “The Bank: Flower + Genetics,’ as well as its precision formulated line of medical cannabis products ‘Nira Plus’. Jushi strives to maximize shareholder value while delivering high premium products across all levels of the cannabis and hemp ecosystem.

Featured Video

Highlights

• Raised roughly $220 million over the last two years
• Approximately $45 million contributed by Founders/Insiders
• Cannabis assets in PA, IL VA, CA, NV, OH; CBD hemp assets in NY
• Projecting 2021 revenue of $205-255 million, with adjusted EBITDA of $40-50 million

Growth Strategy

• Expanding its presence in current markets
• Building a multi-state portfolio of branded cannabis and hemp derived assets through acquisitions, competitive licenses, and expansion within current markets
• Planning to build-out its Pennsylvania retail footprint by increasing the Company’s store count from eight to 15 and leveraging its closed acquisition of a Pennsylvania Grower-Processor to supply the market including its own retail stores
• Seeking approval and opening two additional adult-use Illinois stores for a total of four adult-use operating stores in the state by the end of 2020 or by early first quarter 2021
• Owning one of five licenses in Virginia with the anticipation of adding five additional BEYOND/HELLO™ branded medical dispensaries to its majority owned Dalitso LLC operations
• Targeting acquisition opportunities in limited licenses jurisdictions to become vertically integrated in markets with high barriers of entry
• Applying for de novo licenses for additional avenues of growth in its existing markets and other key markets

Differentiators

• Integrated, metrics-driven business with seamless integration between online and retail
• Experienced management team with proven track record of allocating and raising capital and identifying distressed assets
• Focused portfolio of assets targeted at high-growth medical (PA) and adult-use markets (IL)
• Solid balance sheet; expansion plans fully funded
• Substantial investment to date by management team

Graeme Kreindler, CPA, CA
Eight Capital

Russell Stanley, CFA, MBA
Beacon Securities